CHMP says yes to new Menveo and Proquad vaccines
This article was originally published in Scrip
Executive Summary
The EU's CHMP has given positive opinions to expanded indications to two vaccines, Novartis's Menveo and Sanofi's Proquad, at its latest meeting this week.